Banco Santander (Brasil) S.A. Announces Notice to the Market of Filing of Form 20-F
Banco Santander (Brasil) S.A. Announces Notice to the Market of Filing of Form 20-F
PR Newswire
SAO PAULO, Feb. 26, 2024
SAO PAULO, Feb. 26, 2024 /PRNewswire/ -- Banco Santander (Brasil) S.A. ("Santander Brasil") (NYSE: BSBR) announces that its Annual Report on Form 20-F (the "20–F"), reporting its financial and operational data for 2023, was filed with the U.S. Securities and Exchange Commission, or the SEC, and with the Brazilian Securities and Exchange Commission, the Comissão de Valores Mobiliários, or CVM, on February 26, 2024. The document has been posted on Santander Brasil's website, https://www.santander.com.br/ri.
The 20-F contains detailed information about Santander Brasil, including certifications under the U.S. Sarbanes-Oxley Act, which attest to the effectiveness of Santander Brasil's internal controls and procedures. Santander Brasil's independent auditors, PricewaterhouseCoopers Auditores Independentes, issued an audit opinion on the financial statements and the effectiveness of internal controls over financial reporting as of December 31, 2023.
Santander Brasil's shareholders may receive a hard copy of this document, which contains the Company's complete audited financial statements, free of charge, upon request. Requests should be directed to:
Investor Relations Department
Av. Presidente Juscelino Kubitschek, 2235 - 26º Floor
04543-011 - São Paulo / SP – Brasil
Phone: +55 (11) 3553 3300
E-mail: ri@santander.com.br
BANCO SANTANDER (BRASIL) S.A.
Publicly-Held Company with Authorized Capital
CNPJ/MF: 90.400.888/0001-42
NIRE: 35.300.332.067
Gustavo Alejo Viviani
Investor Relations Officer
View original content:https://www.prnewswire.com/news-releases/banco-santander-brasil-sa-announces-notice-to-the-market-of-filing-of-form-20-f-302071692.html
SOURCE Banco Santander (Brasil) S.A.
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track